13 research outputs found

    Hepatitis B vaccination failure in children with Diabetes Mellitus? The debate continues

    Get PDF
    The aim of our study was to evaluate the presence of specific antibodies against HBsAg in diabetic children (IDDM) previously vaccinated against hepatitis B virus.110 diabetic children were retrospectively studied and 100 healthy controls were recruited. In all patients surface antigen, HBV core IgG, antibodies against HBV "e" antigen and quantitative HBV surface antibodies were detected. In 45 patients molecular typing of HLA alleles was performed. Metabolic control was evaluated as mean glycated hemoglobin (HbA1c) and all patients were compliant to insulin therapy.46 of 110 diabetic children (41.8%) and 16 of 100 healthy controls (16%) were found to have not anti-HBs antibodies (p0.0001). The mean antibody titer was found significantly-lower (p0.0001) in IDDM children than healthy controls. No correlation was found between antibody titer, age, duration of disease and HbA1c. We did not find any difference of gender, age, years of onset of the disease and metabolic control, between diabetics with anti-HBs antibodies and those without.Our data confirm the reduced seroprotection rate for HBV vaccination in diabetics. However it remains poorly clarify the real clinical significance of this result. In our study no diabetic children showed markers of HBV infection

    Cytomegalovirus colitis and cow's milk allergy in an immunocompetent infant: Is a causal or casual relationship?

    Get PDF
    The association between cytomegalovirus (CMV) colitis and cow's milk allergy (CMPA) is rare and still unclear. The authors describe the case of an 8-week old female infant who presented with bloody diarrhea, lack of appetite, weight loss and fever due to CMV colitis. After some months she developed a CMPA. This case report describes the third case of CMV colitis associated with CMPA. This case strongly suggests a causal relationship between the two conditions

    The innovative Cherenkov camera based on SiPM sensors of the ASTRI-Horn telescope: from the T/M and electrical design to the full assembly and testing in a harsh environment

    Get PDF
    ASTRI-Horn is a prototypal telescope of an imaging atmospheric Cherenkov telescope developed by the Italian National Institute of Astrophysics (INAF), proposed for the Cherenkov Telescope Array (CTA) Observatory. The CTA Observatory represents the next generation of imaging atmospheric Cherenkov telescopes and will explore the very highenergy domain from a few tens of GeV up to few hundreds of TeV. It will be composed of large-, medium-, and small sized telescopes; ASTRI-Horn is an end-to-end prototype proposed for the Small Sized array. The main scientific instrument of the ASTRI-Horn telescope is an innovative and compact Camera with Silicon- Photomultiplier based detectors and a specifically designed fast read-out electronics based on a custom peak-detector mode. The thermo-mechanical assembly is designed to host both the entire electronics chain, from the sensors to the raw data transmission system and the calibration system, and the complete thermoregulation system. This contribution gives a high level description of the T/M and electrical design of the Cherenkov Camera, it describes the assembling procedure of its different subsystems and their integration into the complete camera system. A discussion about possible design improvements coming from the problems/difficulties encountered during assembly is also presented. Finally, results from engineering tests conducted in-field are also presented

    The ASTRI camera for the Cherenkov Telescope Array

    Get PDF
    The Cherenkov Telescope Array (CTA) foresees, in its southern site (Chile), the implementation of up to 70 small-sized telescopes (SSTs), which will extend the energy coverage up to hundreds of TeV. It has been proposed that one of the first set of CTA SSTs will be represented by the ASTRI mini-array, which includes (at least) nine ASTRI telescopes. The endto-end prototype of such telescopes, named the ASTRI SST-2M, is installed in Italy and it is now completing the overall commissioning and entering the science verification phase. ASTRI telescopes are characterized by an optical system based on a dual-mirror Schwarzschild-Couder design and a camera at the focal plane composed of silicon photomultiplier sensors managed by a fast read-out electronics specifically designed. Based on a custom peak-detector mode, the ASTRI camera electronics is designed to perform Cherenkov signal detection, trigger generation, digital conversion of the signals and data transmission to the camera server. In this contribution we will describe the main features of the ASTRI camera, its performance and results obtained during the commissioning phase of the ASTRI SST-2M prototype in view of the ASTRI mini-array implementation

    Hepatitis B vaccination failure in children with diabetes mellitus? The debate continues

    No full text
    Background: The aim of our study was to evaluate the presence of specific antibodies against HBsAg in diabetic children (IDDM) previously vaccinated against hepatitis B virus. Results: 46 of 110 diabetic children (41.8%) and 16 of 100 healthy controls (16%) were found not to have anti-HBs antibodies (p &lt; 0.0001). The mean antibody titer was found significantly-lower (p &lt; 0.0001) in IDDM children than healthy controls. No correlation was found between antibody titer, age, duration of disease and HbA1c. We did not find any difference of gender, age, years of onset of the disease and metabolic control, between diabetics with anti-HBs antibodies and those without. Patients and Methods: 110 diabetic children were retrospectively studied and 100 healthy controls were recruited. In all patients surface antigen, HBV core IgG, antibodies against HBV “e” antigen and quantitative HBV surface antibodies were detected. In 45 patients molecular typing of HLA alleles was performed. Metabolic control was evaluated as mean glycated hemoglobin (HbA1c) and all patients were compliant to insulin therapy. Conclusions: Our data confirm the reduced seroprotection rate for HBV vaccination in diabetics. However it remains poorly clarify the real clinical significance of this result. In our study no diabetic children showed markers of HBV infection.Background: The aim of our study was to evaluate the presence of specific antibodies against HBsAg in diabetic children (IDDM) previously vaccinated against hepatitis B virus. Results: 46 of 110 diabetic children (41.8%) and 16 of 100 healthy controls (16%) were found to have not anti-HBs antibodies (p < 0.0001). The mean antibody titer was found significantly-lower (p < 0.0001) in IDDM children than healthy controls. No correlation was found between antibody titer, age, duration of disease and HbA1c. We did not find any difference of gender, age, years of onset of the disease and metabolic control, between diabetics with anti-HBs antibodies and those without. Patients and Methods: 110 diabetic children were retrospectively studied and 100 healthy controls were recruited. In all patients surface antigen, HBV core IgG, antibodies against HBV "e" antigen and quantitative HBV surface antibodies were detected. In 45 patients molecular typing of HLA alleles was performed. Metabolic control was evaluated as mean glycated hemoglobin (HbA1c) and all patients were compliant to insulin therapy. Conclusions: Our data confirm the reduced seroprotection rate for HBV vaccination in diabetics. However it remains poorly clarify the real clinical significance of this result. In our study no diabetic children showed markers of HBV infection. © 2012 Landes Bioscience

    Hepatitis B vaccination failure in children with Diabetes Mellitus? The debate continues

    No full text
    The aim of our study was to evaluate the presence of specific antibodies against HBsAg in diabetic children (IDDM) previously vaccinated against hepatitis B virus.110 diabetic children were retrospectively studied and 100 healthy controls were recruited. In all patients surface antigen, HBV core IgG, antibodies against HBV "e" antigen and quantitative HBV surface antibodies were detected. In 45 patients molecular typing of HLA alleles was performed. Metabolic control was evaluated as mean glycated hemoglobin (HbA1c) and all patients were compliant to insulin therapy.46 of 110 diabetic children (41.8%) and 16 of 100 healthy controls (16%) were found to have not anti-HBs antibodies (p0.0001). The mean antibody titer was found significantly-lower (p0.0001) in IDDM children than healthy controls. No correlation was found between antibody titer, age, duration of disease and HbA1c. We did not find any difference of gender, age, years of onset of the disease and metabolic control, between diabetics with anti-HBs antibodies and those without.Our data confirm the reduced seroprotection rate for HBV vaccination in diabetics. However it remains poorly clarify the real clinical significance of this result. In our study no diabetic children showed markers of HBV infection

    Helicobacter pylori infection and atopic diseases: Is there a relationship? A systematic review and meta-analysis

    No full text
    AIM: To review and conduct a meta-analysis of the existing literature on the relationship between Helicobacter pylori (H. pylori), atopy and allergic diseases. METHODS: Studies published in English assessing the prevalence of atopy and/or allergic diseases in patients with H. pylori infection and the prevalence of H. pylori infection in patients with atopy and/or allergic diseases were identified through a MEDLINE search (1950-2014). Random-effect model was used for the meta-analysis. RESULTS: Pooled results of case-control studies showed a significant inverse association of H. pylori infection with atopy/allergic disease or with exclusively atopy, but not with allergic disease, whereas pooled results of cross-sectional studies showed only a significant association between allergic disease and H. pylori infection. CONCLUSION: There is some evidence of an inverse association between atopy/allergic diseases and H. pylori infection, although further studied are needed

    Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

    No full text
    corecore